392 related articles for article (PubMed ID: 19191340)
1. Adherence to antiparkinson medication in a multicenter European study.
Grosset D; Antonini A; Canesi M; Pezzoli G; Lees A; Shaw K; Cubo E; Martinez-Martin P; Rascol O; Negre-Pages L; Senard A; Schwarz J; Strecker K; Reichmann H; Storch A; Löhle M; Stocchi F; Grosset K
Mov Disord; 2009 Apr; 24(6):826-32. PubMed ID: 19191340
[TBL] [Abstract][Full Text] [Related]
2. Suboptimal medication adherence in Parkinson's disease.
Grosset KA; Bone I; Grosset DG
Mov Disord; 2005 Nov; 20(11):1502-7. PubMed ID: 16037924
[TBL] [Abstract][Full Text] [Related]
3. A multicenter, open-label, sequential study comparing preferences for carbidopa-levodopa orally disintegrating tablets and conventional tablets in subjects with Parkinson's disease.
Nausieda PA; Pfeiffer RF; Tagliati M; Kastenholz KV; DeRoche C; Slevin JT
Clin Ther; 2005 Jan; 27(1):58-63. PubMed ID: 15763606
[TBL] [Abstract][Full Text] [Related]
4. Drug adherence in Parkinson's disease.
Leopold NA; Polansky M; Hurka MR
Mov Disord; 2004 May; 19(5):513-7. PubMed ID: 15133814
[TBL] [Abstract][Full Text] [Related]
5. Medication adherence and associated outcomes in medicare health maintenance organization-enrolled older adults with Parkinson's disease.
Kulkarni AS; Balkrishnan R; Anderson RT; Edin HM; Kirsch J; Stacy MA
Mov Disord; 2008 Feb; 23(3):359-65. PubMed ID: 18074366
[TBL] [Abstract][Full Text] [Related]
6. Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease.
Parkinson Study Group CALM Cohort Investigators
Arch Neurol; 2009 May; 66(5):563-70. PubMed ID: 19433655
[TBL] [Abstract][Full Text] [Related]
7. Sleep complaints and their relation with drug treatment in patients suffering from Parkinson's disease.
Gómez-Esteban JC; Zarranz JJ; Lezcano E; Velasco F; Ciordia R; Rouco I; Losada J; Bilbao I
Mov Disord; 2006 Jul; 21(7):983-8. PubMed ID: 16602112
[TBL] [Abstract][Full Text] [Related]
8. Medication management in people with Parkinson's disease during surgical admissions.
Derry CP; Shah KJ; Caie L; Counsell CE
Postgrad Med J; 2010 Jun; 86(1016):334-7. PubMed ID: 20547599
[TBL] [Abstract][Full Text] [Related]
9. Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis.
Talati R; Baker WL; Patel AA; Reinhart K; Coleman CI
Int J Clin Pract; 2009 Apr; 63(4):613-23. PubMed ID: 19222614
[TBL] [Abstract][Full Text] [Related]
10. Medicine-taking behavior: implications of suboptimal compliance in Parkinson's disease.
Grosset KA; Reid JL; Grosset DG
Mov Disord; 2005 Nov; 20(11):1397-404. PubMed ID: 16092116
[TBL] [Abstract][Full Text] [Related]
11. Levodopa dosage determines adherence to long-acting dopamine agonists in Parkinson's disease.
Santos-García D; Prieto-Formoso M; de la Fuente-Fernández R
J Neurol Sci; 2012 Jul; 318(1-2):90-3. PubMed ID: 22521273
[TBL] [Abstract][Full Text] [Related]
12. Ropinirole is effective on motor function when used as an adjunct to levodopa in Parkinson's disease: STRONG study.
Mizuno Y; Abe T; Hasegawa K; Kuno S; Kondo T; Yamamoto M; Nakashima M; Kanazawa I;
Mov Disord; 2007 Oct; 22(13):1860-5. PubMed ID: 17618525
[TBL] [Abstract][Full Text] [Related]
13. Reducing dosing frequency of carbidopa/levodopa: double-blind crossover study comparing twice-daily bilayer formulation of carbidopa/levodopa (IPX054) versus 4 daily doses of standard carbidopa/levodopa in stable Parkinson disease patients.
Hinson VK; Goetz CG; Leurgans S; Fan W; Nguyen T; Hsu A
Clin Neuropharmacol; 2009; 32(4):189-92. PubMed ID: 19620848
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome of early versus delayed rasagiline treatment in early Parkinson's disease.
Hauser RA; Lew MF; Hurtig HI; Ondo WG; Wojcieszek J; Fitzer-Attas CJ;
Mov Disord; 2009 Mar; 24(4):564-73. PubMed ID: 19086083
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic and pharmacodynamic comparison of ropinirole 24-hour prolonged release and ropinirole immediate release in patients with Parkinson's disease.
Tompson D; Oliver-Willwong R
Clin Neuropharmacol; 2009; 32(3):140-8. PubMed ID: 18978485
[TBL] [Abstract][Full Text] [Related]
16. Assessment of appropriate medication administration for hospitalized patients with Parkinson's disease.
Hou JG; Wu LJ; Moore S; Ward C; York M; Atassi F; Fincher L; Nelson N; Sarwar A; Lai EC
Parkinsonism Relat Disord; 2012 May; 18(4):377-81. PubMed ID: 22236581
[TBL] [Abstract][Full Text] [Related]
17. Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life.
Honig H; Antonini A; Martinez-Martin P; Forgacs I; Faye GC; Fox T; Fox K; Mancini F; Canesi M; Odin P; Chaudhuri KR
Mov Disord; 2009 Jul; 24(10):1468-74. PubMed ID: 19425079
[TBL] [Abstract][Full Text] [Related]
18. Pathological gambling in two patients on dopamine replacement therapy for Parkinson's disease.
Avanzi M; Uber E; Bonfà F
Neurol Sci; 2004 Jun; 25(2):98-101. PubMed ID: 15221629
[TBL] [Abstract][Full Text] [Related]
19. Pain intensity on and off levodopa in patients with Parkinson's disease.
Nebe A; Ebersbach G
Mov Disord; 2009 Jun; 24(8):1233-7. PubMed ID: 19412949
[TBL] [Abstract][Full Text] [Related]
20. First-year treatment adherence among outpatients initiating antihypertensive medication in Korea: results of a retrospective claims review.
Sung SK; Lee SG; Lee KS; Kim DS; Kim KH; Kim KY
Clin Ther; 2009 Jun; 31(6):1309-20. PubMed ID: 19695396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
